IMMUNIZATION AGAINST POLYOMA TUMORS WITH SYNTHETIC PEPTIDES DERIVED FROM THE SEQUENCES OF MIDDLE-T AND LARGE-T ANTIGENS

被引:25
作者
REINHOLDSSONLJUNGGREN, G
RAMQVIST, T
AHRLUND-RICHTER, L
DALIANIS, T
机构
[1] KAROLINSKA INST, DEPT TUMOR BIOL, S-14104 HUDDINGE, SWEDEN
[2] KAROLINSKA INST, NOVUM, CBT, MOLEC GENET UNIT, S-14152 HUDDINGE, SWEDEN
关键词
D O I
10.1002/ijc.2910500128
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have used 9 synthetic peptides corresponding to sequences of polyoma virus small-T, middle-T and large-T antigens as immunogens in order to map antigenic epitopes that can induce polyoma-tumor-specific immunity in different mouse strains. We found that immunization of mice with synthetic peptides derived from amino acid (aa) sequences common to all 3 T-antigens (aa 1-1 9), or sequences common to only middle-T and small-T (aa 162-176), as well as synthetic peptides unique for middle-T (aa 269-282 and 371-381), or unique for large-T (aa 108-124, 316-333 and 436-449) can induce immunity against polyoma tumors. The synthetic peptides can be divided into 3 types with regard to immunogenicity; (i) peptides that immunize in more than one mouse strain and may represent immunodominant sites, (ii) peptides that may be immunogenic in only one strain, and thus strain-specific, and finally (iii) peptides that do not immunize in the strains tested so far.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 20 条